Is better drug availability in secondary neoplasms responsible for better response to chemotherapy?
D000818:Animals; D002277:Carcinoma / Q000188:drug therapy / Q000378:metabolism / Q000556:secondary*; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000378:metabolism / Q000627:therapeutic use*; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy
D004317:Doxorubicin